BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.

Autor: Westaby D; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Jiménez-Vacas JM; The Institute of Cancer Research, London, United Kingdom., Figueiredo I; The Institute of Cancer Research, London, United Kingdom., Rekowski J; The Institute of Cancer Research, London, United Kingdom., Pettinger C; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Gurel B; The Institute of Cancer Research, London, United Kingdom., Lundberg A; The Institute of Cancer Research, London, United Kingdom., Bogdan D; The Institute of Cancer Research, London, United Kingdom., Buroni L; The Institute of Cancer Research, London, United Kingdom., Neeb A; The Institute of Cancer Research, London, United Kingdom., Padilha A; The Institute of Cancer Research, London, United Kingdom., Taylor J; The Institute of Cancer Research, London, United Kingdom., Zeng W; The Institute of Cancer Research, London, United Kingdom., Das S; The Institute of Cancer Research, London, United Kingdom., Hobern E; The Institute of Cancer Research, London, United Kingdom., Riisnaes R; The Institute of Cancer Research, London, United Kingdom., Crespo M; The Institute of Cancer Research, London, United Kingdom., Miranda S; The Institute of Cancer Research, London, United Kingdom., Ferreira A; The Institute of Cancer Research, London, United Kingdom., Hanratty BP; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Nava Rodrigues D; The Institute of Cancer Research, London, United Kingdom., Bertan C; The Institute of Cancer Research, London, United Kingdom., Seed G; The Institute of Cancer Research, London, United Kingdom., Fenor de La Maza MLD; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Guo C; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Carmichael J; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Grochot R; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Chandran K; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Stavridi A; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Varkaris A; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Stylianou N; Australian Prostate Cancer Research Centre-Queensland, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia., Hollier BG; Australian Prostate Cancer Research Centre-Queensland, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia., Tunariu N; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Balk SP; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Carreira S; The Institute of Cancer Research, London, United Kingdom., Yuan W; The Institute of Cancer Research, London, United Kingdom., Nelson PS; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA., Corey E; University of Washington, Seattle, Washington, USA., Haffner M; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA., de Bono J; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Sharp A; The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Sep 17; Vol. 134 (18). Date of Electronic Publication: 2024 Sep 17.

… and the bands play on Gimson AES, Ramage JK, Panos MZ, Hayllar K, Harrison PM, Williams R, Westaby D. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 1993; 342: 391–394

Autor: R Schapiro

Publikováno v: Hepatology. 19:542-543

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d8637e08140e7bf1c6d5acd9fa40476f
https://doi.org/10.1016/0270-9139(94)90037-x

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Autor: Guo C; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Sharp A; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Gurel B; The Institute of Cancer Research, London, UK., Crespo M; The Institute of Cancer Research, London, UK., Figueiredo I; The Institute of Cancer Research, London, UK., Jain S; Northern Ireland Cancer Centre, Belfast, UK.; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Vogl U; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Rekowski J; The Institute of Cancer Research, London, UK., Rouhifard M; The Institute of Cancer Research, London, UK., Gallagher L; The Institute of Cancer Research, London, UK., Yuan W; The Institute of Cancer Research, London, UK., Carreira S; The Institute of Cancer Research, London, UK., Chandran K; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Paschalis A; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Colombo I; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Stathis A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland., Bertan C; The Institute of Cancer Research, London, UK., Seed G; The Institute of Cancer Research, London, UK., Goodall J; The Institute of Cancer Research, London, UK., Raynaud F; The Institute of Cancer Research, London, UK., Ruddle R; The Institute of Cancer Research, London, UK., Swales KE; The Institute of Cancer Research, London, UK., Malia J; The Institute of Cancer Research, London, UK., Bogdan D; The Institute of Cancer Research, London, UK., Tiu C; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Caldwell R; The Royal Marsden NHS Foundation Trust, London, UK., Aversa C; The Royal Marsden NHS Foundation Trust, London, UK., Ferreira A; The Institute of Cancer Research, London, UK., Neeb A; The Institute of Cancer Research, London, UK., Tunariu N; The Royal Marsden NHS Foundation Trust, London, UK., Westaby D; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Carmichael J; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Fenor de la Maza MD; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Yap C; The Institute of Cancer Research, London, UK., Matthews R; The Institute of Cancer Research, London, UK., Badham H; The Institute of Cancer Research, London, UK., Prout T; The Institute of Cancer Research, London, UK., Turner A; The Institute of Cancer Research, London, UK., Parmar M; The Institute of Cancer Research, London, UK., Tovey H; The Institute of Cancer Research, London, UK., Riisnaes R; The Institute of Cancer Research, London, UK., Flohr P; The Institute of Cancer Research, London, UK., Gil J; MRC London Institute of Medical Sciences (LMS), London, UK.; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK., Waugh D; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.; Centre for Cancer Biology, University of South Australia, Adelaide, South Australia, Australia., Decordova S; The Institute of Cancer Research, London, UK., Schlag A; The Institute of Cancer Research, London, UK., Calì B; Institute of Oncology Research, Bellinzona, Switzerland., Alimonti A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Institute of Oncology Research, Bellinzona, Switzerland.; Department of Health Sciences and Technology, Eidgenössische Technische Hochschule Zürich (ETH), Zurich, Switzerland.; Department of Medicine, Veneto Institute of Molecular Medicine, University of Padova, Padua, Italy., de Bono JS; The Institute of Cancer Research, London, UK. johann.debono@icr.ac.uk.; The Royal Marsden NHS Foundation Trust, London, UK. johann.debono@icr.ac.uk.

Publikováno v: Nature [Nature] 2023 Nov; Vol. 623 (7989), pp. 1053-1061. Date of Electronic Publication: 2023 Oct 16.

Erratum to "B7-H3 as a Therapeutic Target in Advanced Prostate Cancer" [Eur Urol 2023;83(3):224-38].

Autor: Guo C; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK., Figueiredo I; The Institute of Cancer Research, London, UK., Gurel B; The Institute of Cancer Research, London, UK., Neeb A; The Institute of Cancer Research, London, UK., Seed G; The Institute of Cancer Research, London, UK., Crespo M; The Institute of Cancer Research, London, UK., Carreira S; The Institute of Cancer Research, London, UK., Rekowski J; The Institute of Cancer Research, London, UK., Buroni L; The Institute of Cancer Research, London, UK., Welti J; The Institute of Cancer Research, London, UK., Bogdan D; The Institute of Cancer Research, London, UK., Gallagher L; The Institute of Cancer Research, London, UK., Sharp A; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK., de la Maza MDF; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK., Rescigno P; Candiolo Cancer Institute, FPO-IRCCS, Candiolo TO, Italy., Westaby D; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK., Chandran K; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK., Riisnaes R; The Institute of Cancer Research, London, UK., Ferreira A; The Institute of Cancer Research, London, UK., Miranda S; The Institute of Cancer Research, London, UK., Calì B; Institute of Oncology Research, Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland., Alimonti A; Institute of Oncology Research, Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland; Veneto Institute of Molecular Medicine, Padova, Italy., Bressan S; Institute of Oncology Research, Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Nguyen AHT; Columbia University Irving Medical Center, New York, NY, USA., Shen MM; Columbia University Irving Medical Center, New York, NY, USA., Hawley JE; Columbia University Irving Medical Center, New York, NY, USA; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA., Obradovic A; Columbia University Irving Medical Center, New York, NY, USA., Drake CG; Columbia University Irving Medical Center, New York, NY, USA; Janssen Research, Spring House, PA, USA., Bertan C; The Institute of Cancer Research, London, UK., Baker C; The Institute of Cancer Research, London, UK., Tunariu N; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK., Yuan W; The Institute of Cancer Research, London, UK., de Bono JS; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.

Publikováno v: European urology [Eur Urol] 2023 Jun; Vol. 83 (6), pp. e168-e169. Date of Electronic Publication: 2023 Mar 22.

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.

Autor: Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Calle B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK., Cheung K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bermudez A; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Marques FJG; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Pye H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Yo EC; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Islam K; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland., Oo HZ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., McClurg UL; Institute for Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Thomas H; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bastian K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Arredondo HM; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Roustan C; Structural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT, London, UK., Gray MA; Sarafan Chem-H and Departemnt of Chemistry, Stanford University, 424 Santa Teresa St, Stanford, CA, 94305, USA., Kelly L; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Tolson A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Mellor E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Haider A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Singh S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Johnston EW; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Punwani S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Knight B; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McCullagh P; Department of Pathology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McGrath J; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Crundwell M; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Harries L; Institute of Biomedical and Clinical Sciences, Medical School, College of Medicine and Health, University of Exeter, Exeter, UK., Bogdan D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Westaby D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Fowler G; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Flohr P; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Yuan W; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Sharp A; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., de Bono J; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Wisnovsky S; University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, BC, V6T 1Z3, Canada., Bertozzi CR; Howard Hughes Medical Institute, 424 Santa Teresa St, Stanford, CA, 94305, USA., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, UK., Guerrero RH; University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza, Spain; Fundación ARAID, 50018, Zaragoza, Spain.; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Leivo J; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Whitaker H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Pitteri S; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Schumann B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK. Jennifer.munkley@ncl.ac.uk.

Publikováno v: Oncogene [Oncogene] 2023 Mar; Vol. 42 (12), pp. 926-937. Date of Electronic Publication: 2023 Feb 01.